Open Access. Powered by Scholars. Published by Universities.®

Digital Commons Network

Open Access. Powered by Scholars. Published by Universities.®

Innovation

SelectedWorks

2007

Medicine and Health Sciences

Articles 1 - 2 of 2

Full-Text Articles in Entire DC Network

Managing A Widespread E-Procurement Implementation In Public Healthcare, Tommaso Federici, Andrea Resca Oct 2007

Managing A Widespread E-Procurement Implementation In Public Healthcare, Tommaso Federici, Andrea Resca

Federici Tommaso

In large parts of Europe, the development of healthcare is subject to contrasting forces. On the one hand, there has been an explosion in spending and, at the same time, governments are faced with strict budget constraints. On the other hand, public healthcare is under pressure to be innovative, technologically advanced and to provide increasingly better quality of services. In this context, eprocurement can be seen as an instrument to offer a solution to the first issue of this dilemma. However, e-procurement initiatives in such domain have not been widely deployed, and most of them have not fully delivered the …


Pharmaceutical Lemons: Innovation And Regulation In The Drug Industry, Ariel Katz Jan 2007

Pharmaceutical Lemons: Innovation And Regulation In The Drug Industry, Ariel Katz

Ariel Katz

Before a new drug can be marketed the Food and Drug Administration must be satisfied that it is safe and effective. According to conventional wisdom, the cost and delay involved in this process diminish the incentives to invest in the development of new drugs. Accordingly, several reforms aimed at restoring such incentives have been implemented and others have been advocated. This paper challenges the central argument in the debate on the topic, namely that drug regulation and drug innovation are necessarily at odds with each other. Although intuitively appealing, the argument that drug regulation negatively affects the incentives to innovate …